Turbine has successfully completed the first phase of its oncology target identification and validation collaboration with Ono
Turbine, the biological simulation company using AI to...
NOETIK, an AI-native biotech company leveraging self-supervised machine learning and high-throughput spatial data to develop next-generation cancer therapeutics, announced that it has been selected...
Company Leverages Causal Machine Learning to Overcome Key Challenges in Developing New Cancer Treatments
PhaseV, a pioneer in software and machine learning (ML) for clinical...
Qritive, a leading digital pathology and AI company headquartered in Singapore, is proud to announce its collaboration with Roche, one of the largest diagnostics and...
CustomerInsights.AI has once again been recognized in the Gartner Hype Cycle for Life Science Commercial Operations, 2024. This marks the second consecutive year CustomerInsights.AI...
Gilead and Genesis Will Leverage the GEMS AI Platform to Generate and Jointly Optimize Molecules Against Selected Targets
Gilead Sciences, Inc. and Genesis Therapeutics, Inc....
Scientist.com, the leading research platform for the pharmaceutical industry, has announced a new partnership with Evotec SE, a leading drug discovery and development company....
Lunit's AI-powered biomarker, Lunit SCOPE PD-L1 TPS, integrates into Roche's navify® Digital Pathology platform to enhance precision medicine and improve cancer biomarker testing
Lunit, a leading...
SyntheticMR is thrilled to announce the appointment of Francois Hebert as the new President of SyntheticMR, North America. With three decades of experience in...